Helix Health and First Databank Partner to Provide Ireland's Leading Advanced Pharmacy Solutions

First DatabankFirst Databank (FDB), the UK's leading provider of drug knowledge bases and clinical decision support, today announced the continuation of the successful partnership with Helix Health. The contract provides Helix Health with FDB's trusted clinical databases for the next three years. Helix Health is continuing to use FDB's information within their product suite in the Republic of Ireland and UK, targeted towards hospital pharmacies and other healthcare sites. FDB's drug knowledge forms a core part of Helix Health's QicScript product range which is tailored to the community pharmacies both in the UK and Republic of Ireland.

Crevan O'Malley, group commercial manager at Helix Health explains why they decided to extend the contract; "We have dealt with First Databank for over 10 years, and they have provided us with an unfailing, high-calibre service over this period. Our customers rely on our products and services and First Databank's clinical databases form a core component to our offer. First Databank is a trusted partner of ours."

FDB's drug knowledge continues to be used within leading healthcare system vendors, hospitals and other healthcare organisations around the globe. Helix Health's product suites are trusted by over 80% of Irish hospitals and nearly 70% of Irish community pharmacies. The combination of the two companies' product strengths, provide reliable and quality solutions for Helix Health's customers. FDB's drug knowledge is featured within the QicScript product range delivering information on more than 10,000 pharmaceutical products to Helix Health's customers. Helix Health's QicScript.net product is a dispensary management system which helps pharmacists to deliver efficient, safe and cost-effective patient services. With advanced clinical support, QicScript.net allows the user to record detailed patient notes. First Databank's drug knowledge provides users with immediate access to comprehensive electronic drug information at the point-of-care which has a number of documented benefits including reduction of medication errors; reduction of costs associated with medication related harm, improved patient care, and improved efficiencies in workflow.

Darren Nichols, managing director at First Databank commented on the contract; "We are delighted that Helix Health has decided to extend their long-standing contract with us. It is testimony to our brilliant team here who provide ongoing support and clinical knowledge to support the Helix Health product range. First Databank's solutions provide clients with access to a depth and breadth of medicines information that is unmatched by any other provider and we are constantly working to develop and enhance our products to meet the market's needs. Long-standing business relationships, like this, only help to develop stronger, more innovative solutions to the market."

The partnership between FDB and Helix Health will ensure the continued development of innovative solutions and delivery of first-class services to customers in the Republic of Ireland and the UK.

Related news articles:

About First DataBank
First DataBank is the UK's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, First DataBank has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen First DataBank to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

Our Multilex Drug Data File - the UK's most comprehensive and widely used drug knowledge base - is in daily use by thousands of healthcare professionals in the UK.

For further information visit www.firstdatabank.co.uk.

Most Popular Now

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...